Home  |  Contact

UniProtKB/Swiss-Prot Q05086: Variant p.Ala201Thr

Ubiquitin-protein ligase E3A
Gene: UBE3A
Variant information

Variant position:  201
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LB/B
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Alanine (A) to Threonine (T) at position 201 (A201T, p.Ala201Thr).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from small size and hydrophobic (A) to medium size and polar (T)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  0
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  201
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  875
The length of the canonical sequence.

Location on the sequence:   LQAKDEDKDEDEKEKAACSA  A AMEEDSEASSSRIGDSSQGD
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         LQAKDEDKDEDEKEKAACSAAAMEEDSEASSSRIGDSSQGD

Mouse                         LQEKDEDKDEDEKEKAACSAAAMEEDSEASSSRMGDSSQGD

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 1 – 875 Ubiquitin-protein ligase E3A
Region 175 – 226 Disordered
Compositional bias 175 – 201 Basic and acidic residues
Modified residue 218 – 218 Phosphoserine


Literature citations

De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome.
Matsuura T.; Sutcliffe J.S.; Fang P.; Galjaard R.-J.; Jiang Y.-H.; Benton C.S.; Rommens J.M.; Beaudet A.L.;
Nat. Genet. 15:74-77(1997)
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM I); VARIANTS TYR-44 AND THR-201;

Mutation analysis of UBE3A in Angelman syndrome patients.
Malzac P.; Webber H.; Moncla A.; Graham J.M. Jr.; Kukolich M.; Williams C.; Pagon R.A.; Ramsdell L.A.; Kishino T.; Wagstaff J.;
Am. J. Hum. Genet. 62:1353-1360(1998)
Cited for: VARIANT AS ILE-826 INS; VARIANTS HIS-62; THR-201 AND PRO-372; INVOLVEMENT IN AS;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.